Qube Research & Technologies LTD Sab Biotherapeutics, Inc. Transaction History

Qube Research & Technologies LTD

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.47 - $0.9 $32 - $62	69 New	69 $0
Q2 2022 Aug 15, 2022	SELL	$1.11 - $3.46 $26,838 - $83,659	-24,179 Closed	0 $0
Q1 2022 May 09, 2022	BUY	$1.78 - $8.5 $13,104 - $62,577	7,362 Added 43.78%	24,179 $91,000
Q4 2021 Feb 01, 2022	BUY	$7.3 - $11.24 $122,764 - $189,023	16,817 New	16,817 $131,000

529K

Ticker SABS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,030,900
Market Cap $172M
Description
SAB Biotherapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of immunotherapies based on human antibodies. It has applied advanced genetic engineering and antibody science to develop transchromosomic bovine herds that produce fully human antibodies targeted at specific diseases, including infectious diseases ...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.